Skip to main content
. 2022 Nov 4;13:986357. doi: 10.3389/fphar.2022.986357

TABLE 3.

Arrhythmia Signal Profiles of Different ICI Strategies.

IC025>0 Ipilimumab Tremelimumab Nivolumab Pembrolizumab Cemiplimab Atezolizumab Avelumab Durvalumab Ipilimumab + Nivolumab Tremelimumab + Durvalumab
Atrioventricular block complete 1.17 2.00 0.73 0.29 1.09
Bundle branch block right −1.57 −1.67 −0.02
Atrioventricular block 0.50 0.18 −1.49 0.90
Bundle branch block left −1.16 −0.63 −0.89
Arrhythmia −0.33 −0.75 −1.03 −2.47 −2.70 −1.58
Bradycardia −1.46 −1.70 −1.95 0.51 −2.96 −3.06
Tachycardia −2.18 0.48 −0.89 −0.45 −0.83 −1.15 −0.58 −0.61
Atrial fibrillation −0.66 0.19 0.12 0.80 −0.51 0.36 0.78 −2.80
Sinus tachycardia −0.26 −0.61 0.14 −1.66 1.76
Atrial flutter 0.62 −0.44 0.53 0.24 1.35
Sinus node dysfunction 0.71 −1.84 −0.90
Supraventricular tachycardia 0.43 0.43 1.36 −1.17 0.42
Cardiac arrest −1.38 −0.35 −1.03 −0.95 0.20 −0.49 0.01 0.47
Sudden death 1.34 1.34 1.08 1.17 −1.21 1.90 0.45
Ventricular tachycardia −0.90 0.59 −0.61
Cardio-respiratory arrest −0.54 −0.87 −1.00 −0.74 −1.59
Ventricular fibrillation −1.32 −0.90